Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Yousef Hajikarimian"'
Autor:
David Clifford, John R. Williams, Terry V. Silk, Christopher P. Ashcroft, Nicholas Murray Thomson, Yousef Hajikarimian, Andrew Derrick, Keith Slucock, Stephen Challenger
Publikováno v:
Organic Process Research & Development. 9:663-669
The development and scale-up of a potential manufacturing route to the endothelin antagonists UK-350,926 1 and UK-349,862 2 are described. A key synthetic challenge in designing an efficient route ...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4b28966a20dd48524c7fffef95182190
https://doi.org/10.1021/op050102f
https://doi.org/10.1021/op050102f
Autor:
Nicholas Murray Thomson, Stephen Challenger, Yousef Hajikarimian, Christopher P. Ashcroft, Andrew Derrick
Publikováno v:
Process Chemistry in the Pharmaceutical Industry, Volume 2: Challenges in an Ever Changing Climate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8c2f27f5f209797a2eaf5a8372451bc7
https://doi.org/10.1201/9781420008357.ch10
https://doi.org/10.1201/9781420008357.ch10
Autor:
Robin Bannister, Lewis Norman John, Amin Shamji, Peter M. Ayrey, Brian M. Adger, Michael Anthony Forth, C. O'farrell, Nicholas Owens, Yousef Hajikarimian
Publikováno v:
Journal of the Chemical Society, Perkin Transactions 1. :2791
A synthesis of methyl 3-(2-methoxy-4-pyridyl)propionate (2), a key intermediate in the synthesis of the potent long-acting histamine H2-receptor antagonist SK&F 93574 (1), is described. The key step in the synthesis of compound (1) involves alkylatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6073bf4f10d41a39b36a2ff2049286e1
https://doi.org/10.1039/p19880002791
https://doi.org/10.1039/p19880002791
Autor:
Adger, Brian M., Ayrey, Peter, Bannister, Robin, Forth, Michael A., Hajikarimian, Yousef, Lewis, Norman J., O'Farrell, Clare, Owens, Nicholas, Shamji, Amin
Publikováno v:
Journal of the Chemical Society, Perkin Transactions 1 (0300922X); Oct1988, Issue 10, p2791-2796, 6p
Autor:
Kumar Gadamasetti, Tamim Braish
As pharmaceutical companies strive to develop safer medicines at a lower cost, they must keep pace with the rapid growth of technology and research methodologies. Defying the misconception of process chemistry as mere scale-up work, Process Chemistry